Family Medicine, Geriatric Medicine · Yonkers, NY
NPI
1720043920
Since 2006
Specialty
Family Medicine, Geriatric Medicine
Code 207QG0300X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
102 Park Ave
Yonkers, NY, 10703
Phone (914) 965-4300
Groups this clinician bills Medicare through
Medicare paid, 2024
$219K
6,791 services
Medicare patients, 2024
280
Average age 75
Drug cost, 2024
$2.8M
13,523 prescriptions
Company payments, 2025
$1,147
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Nasem J Sayegh was code J1071 (injection, testosterone cypionate, 1 mg), 3,011 times for 21 patients. In total Nasem J Sayegh billed 6,791 services in 121 codes, and Medicare paid $219K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-05-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1071 Injection, testosterone cypionate, 1 mg | Office | 3,011 | 21 | $0.02 | $62.45 |
| 36415 Venipuncture Blood Collection | Office | 383 | 195 | $8.64 | $3,308 |
| 99213 Office E&M - Established | Office | 367 | 161 | $80.02 | $29K |
| 99458 E&M - Miscellaneous | Office | 280 | 23 | $35.42 | $9,919 |
| 99233 Hospital E&M - Subsequent | Facility | 260 | 40 | $104.80 | $27K |
| 99457 E&M - Miscellaneous | Office | 232 | 27 | $44.42 | $10K |
| 93000 Electrocardiogram | Office | 222 | 151 | $12.72 | $2,824 |
| 99214 Office E&M - Established | Office | 214 | 123 | $110.73 | $24K |
| 82962 Clinical Chemistry | Office | 190 | 87 | $3.21 | $610 |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 186 | 32 | $55.91 | $10K |
| 71046 X-ray - Chest | Office | 178 | 121 | $29.47 | $5,246 |
| 99454 E&M - Miscellaneous | Office | 159 | 20 | $44.25 | $7,036 |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 121 | 27 | $43.18 | $5,225 |
| 96372 Injection Administration | Office | 80 | 48 | $12.77 | $1,022 |
| 99489 Chronic, Principal, and Transitional Care Management | Office | 65 | 14 | $65.98 | $4,289 |
By year: 2022 $336K for 22,925 services; 2023 $293K for 16,061 services; 2024 $219K for 6,791 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 383 | 195 | $8.64 | $3,308 |
| 82962 Clinical Chemistry | 190 | 87 | $3.21 | $610 |
| 81002 Clinical Chemistry | 35 | 23 | $3.41 | $119 |
Medicare prescription drug claims, 2024
In 2024, the drug Nasem J Sayegh prescribed most often to Medicare patients was Rosuvastatin Calcium, with 746 prescriptions and refills. In total Nasem J Sayegh wrote 13,523 Medicare prescriptions that cost $2.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Rosuvastatin Calcium Generic | 746 | 1,725 | 236 | $8,850 |
| Amlodipine Besylate Generic | 696 | 1,600 | 222 | $3,170 |
| Atorvastatin Calcium Generic | 589 | 1,394 | 191 | $4,439 |
| Losartan Potassium Generic | 567 | 1,281 | 179 | $3,924 |
| Metoprolol Succinate Generic | 550 | 1,224 | 168 | $6,251 |
| Metformin Hcl Generic | 456 | 966 | 142 | $123K |
| Tamsulosin Hcl Generic | 424 | 912 | 127 | $3,966 |
| Jardiance Empagliflozin | 359 | 575 | 90 | $329K |
| Omeprazole Generic | 328 | 673 | 96 | $3,363 |
| Pantoprazole Sodium Generic | 315 | 635 | 88 | $2,594 |
| Losartan-Hydrochlorothiazide Losartan/Hydrochlorothiazide | 312 | 761 | 116 | $4,770 |
| Levothyroxine Sodium Generic | 232 | 516 | 64 | $3,163 |
| Gabapentin Generic | 221 | 340 | 61 | $1,569 |
| Furosemide Generic | 213 | 467 | 84 | $581 |
| Hydrochlorothiazide Generic | 211 | 472 | 67 | $798 |
Brand drugs: 2,576 claims; generic drugs: 10,749 claims; opioid claims: 89.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Nasem J Sayegh $1,147 ($1,147 in general payments such as food, travel and fees) from 11 companies. The largest payer was Novo Nordisk Inc with $437.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 16 | $437 |
| Abbvie Inc. ABBV | 8 | $207 |
| Sumitomo Pharma America, Inc. 4506.T | 21 | $184 |
| Exact Sciences Corporation EXAS | 4 | $97.51 |
| Abbott Laboratories ABT | 5 | $94.24 |
| Merck Sharp & Dohme LLC MRK | 2 | $39.63 |
| Dexcom, Inc. DXCM | 1 | $21.39 |
| Lilly USA, LLC LLY | 1 | $20.37 |
| Novartis Pharmaceuticals Corporation NVS | 1 | $17.75 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 1 | $14.23 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.